Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T15:03:23.722Z.
Calculation as of: 2026-10-06T15:03:23.722Z.
Quote observation: 2026-10-06T15:00:40.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 23bdec7124bcf20b562f8235598f93689ea1cbdfcf2aa7384f68a4c8921eaa93
EARNINGS YIELD
N/A
Market Cap
$8.66B
Earnings Yield
N/A
TTM Avg
2.41%
3Y Avg
2.41%
5Y Avg
2.41%
Market Cap
$8.23B
Earnings Yield
1.23%
TTM Avg
1.38%
3Y Avg
1.38%
5Y Avg
1.38%
Market Cap
$7.70B
Earnings Yield
N/A
TTM Avg
2.30%
3Y Avg
2.30%
5Y Avg
2.30%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Kymera Therapeutics, Inc. (KYMR) | $8.60B | N/A | N/A | N/A | N/A |
| Oscar Health, Inc. (OSCR)vs › | $8.43B | 4.31% | 4.52% | 2.80% | 2.80% |
| Arrowhead Pharmaceuticals, Inc. (ARWR)vs › | $8.66B | N/A | 2.41% | 2.41% | 2.41% |
| Bruker Corporation (BRKRP)vs › | $8.77B | N/A | 0.18% | 0.18% | 0.18% |
| Caris Life Sciences, Inc. (CAI)vs › | $8.23B | 1.23% | 1.38% | 1.38% | 1.38% |
| Axsome Therapeutics, Inc. (AXSM)vs › | $8.95B | N/A | N/A | N/A | N/A |
| Bruker Corporation (BRKR)vs › | $9.13B | N/A | 2.22% | 2.91% | 2.67% |
| Cytokinetics, Incorporated (CYTK)vs › | $7.70B | N/A | 2.30% | 2.30% | 2.30% |
| Insulet Corp. (PODD)vs › | $9.38B | 3.95% | 2.11% | 1.85% | 1.26% |
| HealthEquity, Inc. (HQY)vs › | $7.56B | 3.06% | 2.61% | 1.55% | 1.43% |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
